HOME >> BIOLOGY >> NEWS
Burrowing mayfly swarms signal a healthier ecosystem, USGS scientists say

While swarms of flying insects may have little appeal for most people, USGS biologist Thomas Edsall says the clouds of burrowing mayflies emerging from western Lake Erie this summer are a welcome sign of an ecosystem in recovery.

"They're telling us that the water's clean out there," Edsall says.

Burrowing mayflies are large aquatic insects that spend most of their lives -- about two years -- in their larval form, living in shallow bottom sediments of lakes. On the bottom of western Lake Erie, larval mayflies -- known as nymphs -- once numbered in the hundreds per square meter. But populations decreased dramatically in the 1950s due to deteriorating water quality, and throughout most of the next three decades burrowing mayflies were virtually absent from their former Great Lakes habitat.

For the last five years, however, a remarkable recovery has been under way. Edsall and his colleagues at the USGS Great Lakes Science Center report that nymphs in western Lake Erie have increased from near zero to numbers approaching those of the early twentieth century.

Edsall says the mayfly recovery is a strong sign that improvements in water quality, which have been taking place since the 1970s, have resulted in a healthier, more normally functioning ecosystem. "This is a real tribute to the EPA's enforcement of water pollution control laws, such as the Clean Water Act and U.S. and Canadian cooperation through the Great Lakes Quality Agreement," he says.

USGS and Canadian biologists have used several different methods to determine the past distribution and abundance of burrowing mayflies in Lake Erie and to understand how the insects have responded to different forms of water and sediment of contamination. Sediment core samples, dating back to about 1740, contain jaw parts and other preserved remains that provide a continuous record of burrowing mayfly densities in different regions of the lake. Other information comes from pe
'"/>

Contact: John Gannon
john_e_gannon@brd.usgs.gov
734-214-7237
United States Geological Survey
13-Jul-1999


Page: 1 2 3

Related biology news :

1. Chemical signals health of brain cells Symposium
2. Activated signaling pathway may predict lung cancer patients response to gefitinib
3. NRH1 and Wnt signaling come together in convergent extension
4. Sequential signals choreograph embryonic tubule formation
5. Molecular traffic cop directs cellular signals
6. Stem cells commit to a future of fat with one signal
7. From lung to gut the Wnt signaling pathway transforms cell fate
8. Brain signal predicts working memory prowess
9. Fetal lungs provide a signal initiating labor, UT Southwestern researchers find
10. Ambient light influences the evolution of colour signals
11. Equine clonings triple play sheds light on calcium, cell signaling, human disease

Post Your Comments:
(Date:10/16/2014)... Cancer constantly wages war on the human body. ... a stalemate. In pancreatic cancer, this stalemate—known as ... becoming aggressively malignant, a phenomena that is poorly ... in the laboratory of Salvatore Torquato, a Professor ... the conditions surrounding tumor dormancy and the switch ...
(Date:10/16/2014)... cultivated efficiently, they are anything but sustainable: environmental ... cultivation is becoming increasingly evident. Despite their disadvantages, ... are regarded as the sole possibility of achieving ... finds Bernhard Schmid, an ecology professor at the ... of agriculture and forestry. After all, a new ...
(Date:10/15/2014)... , Oct. 15, 2014 Sandata Technologies, ... home and community-based care, today announced it released ... Sandata,s Santrax® Electronic Visit Verification™ Solution (EVV™)  for ... a home health company founded in 1996 and ... . The study details the ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Sandata Announces Case Study with Quality Care Services, Inc. 2
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... PARK, Calif. , Oct. 20, 2014 /PRNewswire/ ... today that the Company has signed a Notice ... of Regenerative Medicine (CIRM), effective October 1, 2014.  ... Clinical Development payments and the release of additional ... million CIRM grant award for clinical development of ...
(Date:10/20/2014)... Md. , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Zola P. Horovitz , Ph.D., from its board of directors ... board in August 2003, and served as its chairman from ... served on the Nominating and Corporate Governance and Audit Committees ... for more than a decade of dedicated service to GenVec, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2
Cached News: